CD8+ T cells and NK T cells were identified as the most critical tumor-suppressing immune cells by the TIMER-XAI and xCell-XAI analyses, respectively, for the enhanced ≥5-year survivability of the patients. The gene discussed is CD8A; the disease is neoplasm.